Medizia Oncocare offers Bicalutamide Tablets IP 50mg as part of its specialized Anti Cancer Tablets Third Party Manufacturing portfolio for licensed pharmaceutical companies, distributors, hospitals, institutional buyers and other eligible B2B pharmaceutical businesses.
The product shown is marketed under the brand BALETMIDE-50 and is supplied as an oral oncology tablet in a 10 × 10 tablets pack. Current Google-visible oncology manufacturing pages prominently use high-intent terms such as Bicalutamide Tablets manufacturer in India, anti cancer tablets manufacturer, oncology medicine manufacturer, oncology tablets third party manufacturing, oncology contract manufacturing, private label oncology manufacturing, oncology CDMO and bulk oncology medicine supplier. Dedicated oncology CDMOs also list Bicalutamide 50mg and 150mg among anti-cancer tablet products.
Generic Name: Bicalutamide Tablets IP
Strength: 50mg
Brand Name: BALETMIDE-50
Dosage Form: Tablet
Pack Size: 10 × 10 Tablets
Route: Oral Use
Category: Anti Cancer / Oncology Oral Solid
Business Type: Third Party Manufacturing & B2B Pharmaceutical Supply
Pharmaceutical companies searching for a Bicalutamide Tablets 50mg Manufacturer in India generally require a specialized oncology manufacturing partner capable of supporting oral-solid production, tablet compression, quality control, pharmaceutical packaging and commercial B2B supply.
Bicalutamide 50mg is an established oncology tablet strength in India. An Indian Railways approved-product list records Bicalutamide IP 50mg as a film-coated tablet, while current Indian B2B listings show multiple suppliers and manufacturers for Bicalutamide 50mg tablets.
Medizia Oncocare supports eligible B2B requirements related to:
Anti Cancer Tablets Third Party Manufacturing helps pharmaceutical companies expand their oncology product portfolios through established manufacturing infrastructure without developing their own complete specialized production facility.
Current oncology CDMOs manufacture cytotoxic tablets, capsules and sterile injectables and prominently market contract manufacturing, regulatory documentation, commercial manufacturing and dossier support. Bicalutamide is specifically listed as a film-coated tablet in 50mg and 150mg strengths.
Relevant high-intent SEO phrases include:
anti cancer tablets manufacturer India
oncology tablets manufacturer India
Bicalutamide Tablets manufacturer India
oncology tablet third party manufacturing
anti cancer medicine third party manufacturing
oncology contract manufacturer India
oncology CDMO India
Bicalutamide belongs to the specialized oral oncology medicine segment, so appropriate pharmaceutical controls are important during material handling, blending, tablet compression, coating, finished-product testing and packaging.
Important manufacturing considerations can include:
Current dedicated oncology manufacturers emphasize segregated cytotoxic manufacturing and end-to-end oncology production under specialized containment systems.
Current oncology CDMO portfolios list:
Bicalutamide Tablets 50mg
Bicalutamide Tablets 150mg
The showcased Medizia Oncocare product is:
Bicalutamide Tablets IP 50mg – BALETMIDE-50
Useful product-specific search terms include:
Bicalutamide 50mg manufacturer
Bicalutamide Tablets manufacturer India
Bicalutamide third party manufacturer
Bicalutamide tablet supplier India
Bicalutamide contract manufacturer India
Third-party manufacturing can help pharmaceutical businesses add specialized oncology medicines using established production, packaging and quality systems.
Depending on product feasibility and applicable requirements, Medizia Oncocare can support:
Current oncology manufacturing companies also promote end-to-end support ranging from regulatory approvals and material procurement to manufacturing, testing and logistics.
For selected products and subject to manufacturing feasibility, small batch oncology tablet manufacturing may help pharmaceutical businesses introduce specialized products with more manageable initial commercial quantities.
This can be useful for new pharmaceutical companies, businesses launching an oncology division, regional distributors, institutional suppliers and companies developing their own brands.
Minimum manufacturing quantity depends on formulation, packaging specifications, production schedule and applicable regulatory requirements.
Selected oncology products may also be available as ready stock, subject to current commercial and batch availability.
Businesses searching for Bicalutamide Tablets 50mg ready stock, Bicalutamide supplier India, anti cancer tablets ready stock, oncology medicine bulk supplier or Bicalutamide wholesale supplier can enquire regarding current availability.
Current B2B listings show multiple manufacturers and suppliers offering Bicalutamide tablets in India, reinforcing the commercial relevance of these sourcing terms.
The phrase Oncology CDMO is increasingly used by specialist manufacturers providing end-to-end oncology development and manufacturing support.
Current oncology CDMOs emphasize formulation development, analytical development, commercial manufacturing, documentation, regulatory support and supply of cytotoxic tablets, capsules and sterile injectables.
Useful B2B SEO terms include:
oncology contract manufacturing India
Bicalutamide contract manufacturer India
anti cancer tablet contract manufacturer
oncology oral solid manufacturer
oncology pharmaceutical manufacturer India
For pharmaceutical companies developing their own brands, private label oncology manufacturing can combine specialized manufacturing with professional packaging and commercial product presentation.
Depending on project requirements, support may include manufacturing coordination, customized packaging, labeling support, brand presentation, commercial batch planning, bulk production and institutional B2B supply.
Medizia Oncocare operates on a Business-to-Business basis.
Enquiries are intended for licensed pharmaceutical companies, authorized distributors, wholesalers, hospitals, institutional buyers and eligible healthcare procurement organizations holding applicable licences and documentation.
Bicalutamide is a prescription oncology medicine and should be supplied and used only through appropriate professional channels.
Medizia Oncocare supports pharmaceutical businesses searching for a specialized Anti Cancer Tablets Manufacturer and Oncology Third Party Manufacturing Partner with:
If your business is searching for a Bicalutamide Tablets IP 50mg Manufacturer in India, Anti Cancer Tablets Third Party Manufacturer, Oncology Tablet Manufacturer, Oncology Medicine Manufacturer, or Oncology Contract Manufacturing Company, Medizia Oncocare can support eligible B2B pharmaceutical requirements.